Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
32.7%
% of BBP's 55 holdings also in FBT
56.7%
% of FBT's 31 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 2.0% | 3.4% | 2.0% |
|
MODERNA, INC. | 2.0% | 3.3% | 2.0% |
|
INTRA-CELLULAR THERAPIES INC | 2.0% | 3.8% | 2.0% |
|
NEUROCRINE BIOSCIENCES INC | 1.9% | 3.4% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.9% | 3.4% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to FBT
|
TARSUS PHARMACEUTICALS, INC. | 3.5% |
|
LEXICON PHARMACEUTICALS, INC. | 3.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.6% |
|
AGIOS PHARMACEUTICALS INC | 2.5% |
|
ADMA BIOLOGICS, INC. | 2.5% |
|
SAREPTA THERAPEUTICS INC | 2.4% |
|
CRISPR THERAPEUTICS AG | 2.4% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | 2.3% |
|
ASCENDIS PHARMA A/S | 2.3% |
|
AMYLYX PHARMACEUTICALS, INC. | 2.3% |
BBP Underweight Relative to FBT
|
CATALYST PHARMACEUTICAL PART | -3.4% |
 |
GENMAB A/S SPONSORED ADR | -3.4% |
 |
ALKERMES PLC | -3.4% |
|
CORCEPT THERAPEUTICS INC | -3.4% |
 |
ARGENX SE ADR | -3.3% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.2% |
|
ILLUMINA INC | -3.2% |
|
BEAM THERAPEUTICS, INC. | -3.2% |
|
WATERS CORP | -3.2% |
|
REPLIGEN CORP | -3.2% |